Library
2-كلورو-4،5-ميثيلين ديوكسي أمفيتامين
6-Chloro-MDA, also known as 6-chloro-3,4-methylenedioxyamphetamine or as 2-chloro-4,5-methylenedioxyamphetamine (2-Cl-4,5-MDA), is a psychoactive drug of the phenethylamine, amphetamine, and MDxx families related to 3,4-methylenedioxyamphetamine (MDA). It is the 6-chloro derivative of MDA. The drug has an active dose of 160 mg orally and a duration of approximately 8 hours. It is a weak monoamine oxidase inhibitor (MAOI). 6-Chloro-MDA was first described in the scientific literature by 1970. The properties of 6-chloro-MDA in humans were described by Daniel Trachsel and colleagues in 2013 via personal communication with P. Rausch in 2009.
Classification
- Chemical: Amphetamine
- Chemical: Phenethylamine
- Psychoactive: Stimulant
Effects
- Increased Heart Rate
- Stimulation
- Insomnia
- Loss Of Appetite
- Jaw Tension
- Talkativeness
- Alertness Enhancement
- Euphoria
- Anxiety
- Irritability
- Light Sensitivity
- Appetite Suppression
- Increased Libido
- Open Eye Visuals
- Auditory Hallucination
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
